AIDS Healthcare Foundation (AHF) applauds the U.S. Federal Trade Commission (FTC) for taking decisive action against pharmacy benefit managers (PBMs) that drive up costs for insulin, a product never ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

The FTC’s complaint accuses Optum Rx and other pharmacy benefit managers of “abusing their economic power." Optum called the ...

Related FDA approves FluMist for upcoming flu season FTC sues prescription drug middlemen, alleging they conspired over high ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

The owner of one of the three largest pharmacy middlemen in the United States last week filed ... against the three pharmacy ...

Reuters reported that the court did not address the merits of the case, only that a Texas judge was wrong to dismiss it in February. Meanwhile, the Federal Trade Commission has accused the three ...

PBMs are companies that serve as middlemen to ... the state sued the drug manufacturers Novo Nordisk, Sanofi and Eli Lilly, ...

Caremark, Express Scripts, Optum and their GPOs created a rebate system that boosted PBM profits, FTC alleges.

The FTC is suing three pharmacy benefit managers for allegedly driving up the cost of insulin, but there is very little other ...

The disparity between patients with public and private insurance may play into a further inequality of prenatal diagnoses of ...

Deteriorating conditions can send people to the ER with falls and injuries. And toxic pollutants contribute to health ...